Keyphrases
Levodopa
100%
Protein Kinase
100%
6-hydroxydopamine (6-OHDA)
100%
Dyskinetic
100%
Cannabinoid Agonists
100%
WIN55,212-2
100%
Striatal
60%
Hyperactivity
40%
Dyskinesia
40%
CB 1
40%
DARPP-32
40%
Parkinson's Disease
20%
Threonine
20%
Signaling Pathway
20%
Antagonism
20%
Phosphorylation
20%
Effective Strategies
20%
Phosphoprotein
20%
Systemic Administration
20%
Levodopa-induced Dyskinesia
20%
Cause of Disease
20%
Abnormal Involuntary Movements
20%
CB1 Receptor
20%
Motor Complications
20%
Protein Kinase A Signaling
20%
Protein Kinase A Activity
20%
Rat Model of Parkinson's Disease
20%
Motor Disturbances
20%
6-OHDA Rat Model
20%
Pharmacology, Toxicology and Pharmaceutical Science
Levodopa
100%
Cyclic AMP Dependent Protein Kinase
100%
Cannabinoid
100%
Dyskinesia
50%
Hyperactivity
33%
Phosphoprotein DARPP 32
33%
Parkinson's Disease
33%
Rat Model
16%
Receptor
16%
Motor Dysfunction
16%
Phosphoprotein
16%
Systemic Administration
16%
Threonine
16%
Levodopa-Induced Dyskinesia
16%